Pharmaceutical Manufacturing Market by Drug Development Type (In-House, Outsource), Formulation (Capsules, Injectable, Powders), Therapy Area, Route of Administration, Prescription, Age Group, Distribution Channels - Global Forecast 2023-2030

Pharmaceutical Manufacturing Market by Drug Development Type (In-House, Outsource), Formulation (Capsules, Injectable, Powders), Therapy Area, Route of Administration, Prescription, Age Group, Distribution Channels - Global Forecast 2023-2030


The Pharmaceutical Manufacturing Market size was estimated at USD 509.45 billion in 2022 and expected to reach USD 572.30 billion in 2023, at a CAGR 12.47% to reach USD 1,304.53 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pharmaceutical Manufacturing Market.
  • Based on Drug Development Type, market is studied across In-House and Outsource. The In-House is projected to witness significant market share during forecast period.
  • Based on Formulation, market is studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets. The Sprays is projected to witness significant market share during forecast period.
  • Based on Therapy Area, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases. The Cardiovascular Diseases is projected to witness significant market share during forecast period.
  • Based on Route of Administration, market is studied across Inhalations, Oral, Parenteral, and Topical. The Inhalations is projected to witness significant market share during forecast period.
  • Based on Prescription, market is studied across Over-the-Counter (OTC) Medicines and Prescription Medicines. The Over-the-Counter (OTC) Medicines is projected to witness significant market share during forecast period.
  • Based on Age Group, market is studied across Adults, Children & Adolescents, and Geriatric. The Adults is projected to witness significant market share during forecast period.
  • Based on Distribution Channels, market is studied across Non-Retail and Retail. The Non-Retail is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pharmaceutical Manufacturing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pharmaceutical Manufacturing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pharmaceutical Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Pvt. Ltd., Aenova Group GmbH, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim Group, Bristol-Myers Squibb, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd., Famar SA, GlaxoSmithKline PLC, Johnson & Johnson Private Limited, Lonza Group AG, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Piramal Pharma Solutions, Recipharm AB, Sanofi S.A., and Sun Pharmaceutical Industries Limited.

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Pharmaceutical Manufacturing Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Pharmaceutical Manufacturing Market?
  3. What is the competitive strategic window for identifying opportunities in the Pharmaceutical Manufacturing Market?
  4. What are the latest technology trends and regulatory frameworks in the Pharmaceutical Manufacturing Market?
  5. What is the market share of the leading vendors in the Pharmaceutical Manufacturing Market?
  6. Which modes and strategic moves are suitable for entering the Pharmaceutical Manufacturing Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Manufacturing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in global demand for vaccines and drugs
5.1.1.2. Growing pharmaceutical R&D spending
5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
5.1.2. Restraints
5.1.2.1. Complexities associated with the production
5.1.3. Opportunities
5.1.3.1. Rise in the investment and funding programs in pharmaceutical manufacturing sector
5.1.3.2. Emergence in the advancements of pharmaceutical manufacturing technologies
5.1.4. Challenges
5.1.4.1. Logistics complexities and limited skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Pharmaceutical Manufacturing Market, by Drug Development Type
6.1. Introduction
6.2. In-House
6.3. Outsource
7. Pharmaceutical Manufacturing Market, by Formulation
7.1. Introduction
7.2. Capsules
7.3. Injectable
7.4. Powders
7.5. Sprays
7.6. Suspensions
7.7. Tablets
8. Pharmaceutical Manufacturing Market, by Therapy Area
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Pain
8.6. Respiratory Diseases
9. Pharmaceutical Manufacturing Market, by Route of Administration
9.1. Introduction
9.2. Inhalations
9.3. Oral
9.4. Parenteral
9.5. Topical
10. Pharmaceutical Manufacturing Market, by Prescription
10.1. Introduction
10.2. Over-the-Counter (OTC) Medicines
10.3. Prescription Medicines
11. Pharmaceutical Manufacturing Market, by Age Group
11.1. Introduction
11.2. Adults
11.3. Children & Adolescents
11.4. Geriatric
12. Pharmaceutical Manufacturing Market, by Distribution Channels
12.1. Introduction
12.2. Non-Retail
12.3. Retail
13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.2. Market Share Analysis, By Key Player
16.3. Competitive Scenario Analysis, By Key Player
17. Competitive Portfolio
17.1. Key Company Profiles
17.1.1. Actiza Pharmaceutical Pvt. Ltd.
17.1.2. Aenova Group GmbH
17.1.3. AstraZeneca PLC
17.1.4. Bayer AG
17.1.5. Boehringer Ingelheim Group
17.1.6. Bristol-Myers Squibb
17.1.7. Cipla Limited
17.1.8. Eli Lilly and Company
17.1.9. F. Hoffmann-La Roche AG
17.1.10. F. Hoffmann-La Roche Ltd.
17.1.11. Famar SA
17.1.12. GlaxoSmithKline PLC
17.1.13. Johnson & Johnson Private Limited
17.1.14. Lonza Group AG
17.1.15. Merck & Co., Inc.
17.1.16. Novartis AG
17.1.17. Novo Nordisk A/S
17.1.18. Pfizer, Inc.
17.1.19. Piramal Pharma Solutions
17.1.20. Recipharm AB
17.1.21. Sanofi S.A.
17.1.22. Sun Pharmaceutical Industries Limited
17.2. Key Product Portfolio
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings